Quality and Pharmaceutical Equivalence Determinations of Commercially Available Amlodipine Besylate Immediate Release Tablets
Pharmacology & Pharmacy · 2022 · 13 (05) · 129-139
DOI: 10.4236/pp.2022.135010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology & Pharmacy, 2022. Verfasst von Farhana Afroz und 4 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Afroz, F., Sharmin, S., Rony, S. R., Moni, F., & Sohrab, M. H. (2022). Quality and Pharmaceutical Equivalence Determinations of Commercially Available Amlodipine Besylate Immediate Release Tablets. Pharmacology & Pharmacy, 13(05), 129-139. https://doi.org/10.4236/pp.2022.135010
Vancouver
Afroz F, Sharmin S, Rony SR, Moni F, Sohrab MH. Quality and Pharmaceutical Equivalence Determinations of Commercially Available Amlodipine Besylate Immediate Release Tablets. Pharmacology & Pharmacy. 2022;13(05):129-139. doi:10.4236/pp.2022.135010
BibTeX
@article{Afroz2022,
author = {Afroz, Farhana and Sharmin, Suriya and Rony, Satyajit Roy and Moni, Fatema and Sohrab, Md. Hossain},
title = {Quality and Pharmaceutical Equivalence Determinations of Commercially Available Amlodipine Besylate Immediate Release Tablets},
journal = {Pharmacology & Pharmacy},
year = {2022},
volume = {13},
number = {05},
pages = {129--139},
doi = {10.4236/pp.2022.135010}
}
EUVIMED